Odessa, FL – According to filings with the U.S. Securities and Exchange Commission, VuEssence is raising $2,100,000.00 in new funding. Sources indicate as part of senior management President, Maha Sallam played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About VuEssence

VuEssence is a development stage company focused on creating molecular diagnostic solutions to aid in the detection, management and understanding of disease. We rely on utilizing advanced technologies designed to decipher the human genome and transcription. Our aim is to develop practical solutions that can truly assist physicians with the difficult task of managing patients with serious conditions.Our hope is to make a significant impact by improving the outcome of treatment and the lives of patients.

To learn more about VuEssence, visit http://www.vuessence.com/

Contact:
Maha Sallam, President
813-792-7123
msallam@vuessence.com
https://www.linkedin.com/in/maha-sallam-b32b2713/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved